Showing results (131-140 of 413) with videos related to
Sort By:
Pageof 42
Gut|June 14, 2022
COVID-19 and liver diseaseJean-François Dufour, Thomas Marjot, Chiara Becchetti, et al.Current Pharmaceutical Design|March 29, 2018
Paneth Cells and their Antimicrobials in Intestinal ImmunityTimon E Adolph, Lisa Mayr, Felix Grabherr, et al.Nature Reviews. Immunology|August 8, 2019
The intestinal microbiota fuelling metabolic inflammationHerbert Tilg, Niv Zmora, Timon E Adolph, et al.Gut|November 26, 2024
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonistsGiovanni Targher, Alessandro Mantovani, Christopher D Byrne, et al.Gut|May 22, 2024
Heavy arch: from inflammatory bowel diseases to metabolic disordersTimon E Adolph, Moritz Meyer, Almina Jukic, et al.Nature Reviews. Gastroenterology & Hepatology|May 2, 2018
Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver diseaseQuentin M Anstee, Alessandro Mantovani, Herbert Tilg, et al.Wiener Klinische Wochenschrift|April 14, 2019
[Smoking, alcohol and diabetes (Update 2019)]Helmut Brath, Susanne Kaser, Christian Tatschl, et al.Gut|July 24, 2020
Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humansChristoph Grander, Benedikt Schaefer, Julian Schwärzler, et al.Nature Reviews. Gastroenterology & Hepatology|September 29, 2019
Translating the gut microbiome: ready for the clinic?Susan V Lynch, Siew C Ng, Fergus Shanahan, et al.Molecular Aspects of Medicine|May 24, 2020
Intravenous iron supplementation therapyBenedikt Schaefer, Eva Meindl, Sonja Wagner, et al.Pageof 42